FIELD: medicine, hepatology, pharmacy. SUBSTANCE: invention proposes novel component of pharmaceutical composition, food composition or beverage used for prophylaxis or treatment of hepatic lipid dystrophy or hepatic cirrhosis in mammals, among them, humans. As such component the known flavonoids naringin or naringenin are used. EFFECT: expanded assortment of agents of designation claimed. 9 cl, 6 dwg, 6 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HESPERIDIN AND HESPERETIN AS INHIBITOR OF ACYL-COA-CHOLESTEROL-O- ACYLTRANSFERASE, INHIBITORS OF ACCUMULATION OF COMPLEXES MACROPHAGE-LIPID ON ARTERY WALLS AND AS AGENT FOR PROPHYLAXIS OR TREATMENT OF DISEASES | 1998 |
|
RU2197239C2 |
| NARINGIN AND NARINGENIN AS INHIBITOR OF ACTIVITY OF 3-HYDROXY-3-METHYLGLUTARYL-COA-REDUCTASE | 1997 |
|
RU2174393C2 |
| CITRUS FRUIT PEEL EXTRACT AS INHIBITOR OF 3-HYDROXY-3-METHYL-GLUTARYL-COA-REDUCTASE | 1997 |
|
RU2173164C2 |
| HESPERIDIN AND HESPERETIN AS INHIBITORS OF 3-HYDROXY-3-METHYL-GLUTARYL-COA-REDUCTASE | 1997 |
|
RU2174392C2 |
| BIOFLAVONOIDS AS BLOOD GLUCOSE LEVEL- DECREASING AGENT | 1998 |
|
RU2203050C2 |
| INSECTICIDE COMPOSITIONS CONTAINING COMPOUNDS WITH INHIBITOR ACTIVITY AGAINST ACYL-CoA:CHOLESTEROL ACYLTRANSFERASE OR SALTS THEREOF AS ACTIVE INGREDIENTS | 2003 |
|
RU2305403C2 |
| COMPOSITION CONTAINING MONEYWORT EXTRACT FOR PREVENTING AND TREATING METABOLIC DISORDERS | 2008 |
|
RU2481851C2 |
| METHOD OF INHIBITING SUCTION AND/OR INCREASING LIPID RELEASE WITH USING D-PSICOSE | 2016 |
|
RU2725145C2 |
| MACROPOROUS CHITOSAN GRANULES AND METHOD FOR THEIR PREPARING, METHOD FOR CULTURING CELLS | 2000 |
|
RU2234514C2 |
| COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OBESITY OR FATTY LIVER DISEASE CONTAINING LEUCONOSTOC CITREUM WiKim0104 | 2020 |
|
RU2816754C2 |
